Document:

QuickLinks
 -- Click here to rapidly navigate through this document

 
 

  Exhibit 10.9    
    

 SECOND AMENDMENT TO SECOND LIEN CREDIT AGREEMENT, WAIVER AND CONSENT  

        THIS SECOND AMENDMENT TO SECOND LIEN CREDIT AGREEMENT, WAIVER AND CONSENT (as the same may from time to time be amended, restated or
otherwise modified, this "Agreement") is made as of May 15, 2008 and entered into by and among PROSPECT MEDICAL HOLDINGS, INC.
("Holdings") and PROSPECT MEDICAL GROUP, INC. ("Group" and, together with Holdings, the
"Borrowers" and each, individually, a "Borrower"), BANK OF AMERICA, N.A., as Administrative Agent (in
such capacity, the "Second Lien Administrative Agent"), and the lenders party hereto (collectively, the "Second Lien
Lenders"). 

 RECITALS  

        A.    The
Borrowers, the Second Lien Lenders and the Second Lien Administrative Agent have entered into that certain Second Lien Credit Agreement dated as of August 8,
2007 (as amended by that certain Amended and Restated Forbearance Agreement dated as of April 10, 2008, as amended hereby and as further amended, restated, supplemented or otherwise modified,
the "Second Lien Credit Agreement"), pursuant to which the Second Lien Lenders have agreed to make the Loans (such term, together with each other
capitalized term used in this Agreement but not defined in this Agreement, shall be defined in accordance with the Second Lien Credit Agreement) and other extensions of credit, all upon the terms and
conditions set forth in the Second Lien Credit Agreement. 

        B.    The
Borrowers acknowledge and agree that the Defaults and Events of Default set forth on Schedule A (the
"Existing Events of Default") have occurred under the Second Lien Credit Agreement; accordingly, the Borrowers have requested the Second Lien Lenders to
waive such Defaults and Events of Default. 

        C.    The
Borrowers have also requested that the Second Lien Administrative Agent and the Second Lien Lenders consent to the Sale (as defined below). 

        D.    The
Borrowers have also requested that the Second Lien Administrative Agent and the Second Lien Lenders agree to certain amendments to the Second Lien Credit Agreement. 

        E.    Subject,
in each case, to the terms and conditions hereof, the Second Lien Lenders are willing to grant the Borrowers' requests. 

        F.     In
consideration of the agreements hereinafter set forth, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the
parties hereto agree as follows: 

 AGREEMENT  

        1.     Defaults and Waiver.    Subject to the terms and conditions hereof, including, without limitation, the
conditions to effectiveness set forth in Section 4, the Second Lien Administrative Agent and the Second Lien Lenders hereby waive the Existing
Events of Default. 

        2.     Consent to Sale.    Notwithstanding anything to the contrary set forth in the Second Lien Credit Agreement, the
Second Lien Lenders and the Second Lien Administrative Agent hereby consent to the sale (the "Sale") of all of the issued and outstanding stock of
Sierra Medical Management, Inc. ("SMM"), Sierra Primary Care Medical Group, A Medical Corporation
("Sierra"), Antelope Valley Medical Associates, Inc. ("Antelope Valley") and Pegasus Medical
Group, Inc. ("Pegasus") to Greater Midwest ("Greater Midwest") and Sierra Medical Group Holding
Company, Inc. ("Heritage PC", together with Greater Midwest, the "Buyers") and waive any Event of
Default (including, without 

 

limitation,
any Change of Control) that would otherwise be caused by the consummation of the Sale, subject to the satisfaction of each of the conditions precedent set forth below and
in Section 4:

        (a)   The
Second Lien Administrative Agent shall have received true, correct and complete copies of: (i) the executed Stock Purchase Agreement (including all exhibits
and schedules thereto) dated as of April 23, 2008, by and among the Borrowers, the Buyers and Richard Merkin, M.D., in respect of the Sale; (ii) the Escrow Agreement dated as of
April 23, 2008, by and among the Borrowers, the Buyers, and LaSalle Bank National Association, as escrow agent; and (iii) the letter agreement regarding early execution dated as of
April 23, 2008, from Greater Midwest to Holdings (collectively, the "Sale Documents"). 

        (b)   The
terms and conditions of the Sale and the Sale Documents shall be in form and substance satisfactory to the Second Lien Lenders and the Second Lien Administrative
Agent. 

        (c)   The
First Lien Lenders and the First Lien Administrative Agent shall have consented to the Sale and approved the Sale Documents. 

        (d)   The
Borrowers shall prepay the Term Loans under the First Lien Credit Agreement (which prepayment shall not be subject to any prepayment premium or other penalty) in an
amount equal to one hundred percent (100%) of the Net Cash Proceeds (as defined in the First Lien Credit Agreement and including all severance and tail insurance premiums paid in connection with the
sale) and equal to at least $7,000,000 by directing the Buyers to remit the Net Cash Proceeds payable to the Borrowers in connection with the Sale directly to the First Lien Administrative Agent in
accordance with wire transfer instructions to be provided thereby. 

        3.     Amendments to the Second Lien Credit Agreement.    The Second Lien Administrative Agent, the Second Lien Lenders
and the Borrowers agree to amend, effective in accordance with Section 4 below, the Second Lien Credit Agreement as follows: 

        (a)   The
definition of "Applicable Rate" in Section 1.01 of the Second Lien Credit Agreement is hereby amended and
restated in its entirety to read as follows: 

        "'Applicable Rate' means the applicable percentage per annum set forth below determined by reference to the Consolidated Leverage Ratio as
set forth in the most recent Compliance Certificate received by the Administrative Agent pursuant to Section 6.02(b): 

											
	Applicable Rate 	 
	Pricing

Level

 
	 	Consolidated Leverage Ratio 	 	Eurodollar

Rate 	 	Base Rate 	 
	 	1	 	Less than 2.50:1.00	 	 	10.00	%	 	9.00	%
	 	2	 	Greater than or equal to 2.50:1.00 but less than 3.00:1.00	 	 	11.00	%	 	10.00	%
	 	3	 	Greater than or equal to 3.00:1.00	 	 	11.75	%	 	10.75	%

        Any
increase or decrease in the Applicable Rate resulting from a change in the Consolidated Leverage Ratio shall become effective as of the first Business Day immediately following the
date a Compliance Certificate is delivered pursuant to Section 6.02(b); provided,  however, that if a
Compliance Certificate is not delivered when due in accordance with such Section, then Pricing Level 3 shall apply, in each
case as of the first Business Day after the date on which such Compliance Certificate was required to have been delivered. 

        Notwithstanding
anything to the contrary contained in this definition, if, as a result of any restatement of or other adjustment to the financial statements of Holdings or for any other
reason, either Borrower or the Lenders determine that (i) the Consolidated Leverage Ratio as calculated by the Borrowers as of any applicable date was inaccurate and (ii) a proper
calculation of the Consolidated Leverage Ratio would have resulted in higher pricing for such period, the Borrowers shall immediately and retroactively be obligated to pay to the Administrative Agent
for the account of the 

2

 

applicable
Lenders, promptly on demand by the Administrative Agent (or, after the occurrence of an actual or deemed entry of an order for relief with respect to either Borrower under the Bankruptcy
Code of the United States, automatically and without further action by the Administrative Agent or any Lender), an amount equal to the excess of the amount of interest and fees that should have been
paid for such period over the amount of interest and fees actually paid for such period. This paragraph shall not limit the rights of the Administrative Agent or any Lender, as the case may be, under
Section 2.08(b) or under Article VIII. The Borrowers' obligations under this paragraph shall
survive the termination of the Term Commitments and the repayment of all other Obligations hereunder." 

        (b)   The
definition of "Consolidated EBITDA" in Section 1.01 of the Second Lien Credit Agreement is hereby amended by
(i) amending and restating the following clauses: (A) in subsection (b)(iii), the clause "(iii) losses (or plus gains)" is hereby amended to read as follows "(iii) gains (or plus
losses)" and (B) in subsection (b)(iv), the clause "plus (iv) extraordinary losses (or plus gains)" is hereby amended to read as follows "and (iv) extraordinary gains (or
plus extraordinary losses)" and (ii) adding the following new sentence at the end of such definition: 

        "For
purposes of clarification, it is understood and agreed that the add-backs identified on Schedule 1.01 shall not
apply to any compliance period ending after March 31, 2008." 

        (c)   The
definition of "Dr. Terner" in Section 1.01 of the Second Lien Credit Agreement is hereby amended by
adding the following clause at the end of such definition: ", or such other licensed physician reasonably acceptable to the Administrative Agent;  provided, that the Administrative Agent shall have
received at least thirty (30) days prior written notice of any such replacement and all Loan
Document amendments, agreements, certificates and other documents requested thereby in connection with any such replacement." 

        (d)   The
definition of "Fee Letter" in Section 1.01 of the Second Lien Credit Agreement is hereby amended and restated
in its entirety to read as follows: 

        "'Fee Letter' means the letter agreement, dated May 23, 2007, among the Borrowers, the Administrative Agent and the Arranger, as
amended, restated, supplemented or otherwise modified from time to time." 

        (e)   The
definition of "Indebtedness" in Section 1.01 of the Second Lien Credit Agreement is hereby amended in the
following manner: 

          (i)  By
adding the following phrase immediately prior to the ";" at the end of item "(c)" within such definition: "(provided, however, that the net obligations of such
Person under any Swap Contracts shall not be included as Indebtedness for purposes of calculating covenant compliance under Section 7.11(a)
hereof)"; and 

         (ii)  by
amending and restating item "(i)" within such definition in its entirety to read as follows: 

        "(i)
all overpayment settlements or similar obligations owing in respect of Medicare/Medicaid evidenced by a letter agreement or other structured settlement." 

        (f)    The
definition of "Loan Document" in Section 1.01 of the Second Lien Credit Agreement is hereby amended and
restated in its entirety to read as follows: 

        "'Loan Documents' means, collectively, (a) this Agreement, (b) the Notes, (c) the Guaranty, (d) the Collateral
Documents, (e) the Fee Letter, (f) each Secured Hedge Agreement, (g) each Secured Cash Management Agreement, (h) the Terner Pledge and (i) each other document and
agreement executed in connection herewith or related hereto that identifies itself as a "Loan Document"; provided that for purposes of the definition of 

3

 

"Material
Adverse Effect" and Articles IV through IX, "Loan Documents" shall not include Secured
Hedge Agreements or Secured Cash Management Agreements." 

        (g)   The
definition of "Measurement Period" in Section 1.01 of the Second Lien Credit Agreement is hereby amended and
restated in its entirety as follows: 

        "'Measurement Period' means, at any date of determination, the most recently completed twelve months or four fiscal quarters, as
applicable, of Holdings." 

        (h)   The
definition of "Term Loan" is hereby amended by adding the following phrase just prior to the period in such definition "and the Term PIK Fee Obligation". 

        (i)    The
following definitions are hereby added to Section 1.01 of the Second Lien Credit Agreement in alphabetical
order: 

        "'Second Amendment Effective Date' means May 15, 2008." 

        "'Term PIK Fee Obligation' means the fee paid to the consenting Term Lenders pursuant to Section 4(f)(ii) of the Second Amendment
to the Second Lien Credit Agreement, Waiver and Consent dated as of May 15, 2008. The Term PIK Fee Obligation shall be deemed to be a Term Loan for all purposes of this Agreement and the other
Loan Documents. The Term PIK Fee Obligation shall be deemed to be fully earned as of the Second Amendment Effective Date." 

        (j)    Section 2.05(a)(ii)(A)
of the Second Lien Credit Agreement is hereby amended by deleting the phrase "prior to the second anniversary of the Closing Date" in the
second sentence thereof and substituting in lieu thereof the following phrase "prior to December 8, 2009". 

        (k)   Section 2.05(a)(ii)(B)
of the Second Lien Credit Agreement is hereby amended by amending and restating such subsection in its entirety to read as follows: 

        "(B)
Notwithstanding anything herein to the contrary, all prepayments of the Term Loan that are made in accordance with this  Section 2.05(a) prior to (1) May 15, 2010, but on or after
December 8, 2009, shall be subject to an additional premium equal
to the amount of such prepayment multiplied by 4.5%, with respect to each such prepayment made prior to May 15, 2010, (2) the third anniversary of the Closing Date, but on or after
May 15, 2010, shall be subject to an additional premium equal to the amount of such prepayment multiplied by 3%, with respect to each such prepayment made prior to the third anniversary of the
Closing Date, (3) the fourth anniversary of the Closing Date but on or after the third anniversary of the Closing Date shall be subject to an additional premium equal to the amount of such
prepayment multiplied by 2%; and (4) the fifth anniversary of the Closing Date but on or after the fourth anniversary of the Closing Date shall be subject to an additional premium equal to the
amount of such prepayment multiplied by 1%. On or after the fifth anniversary of the Closing Date, no premiums or penalties shall be payable pursuant to this  Section 2.05(a)(ii) in connection with
any prepayments of the Term Loan." 

        (l)    Section 2.05(b) of the Second Lien Credit Agreement is amended by: 

          (i)  Deleting
each instance of the parenthetical "(such prepayments to be applied as set forth in clause (v) below)" therein. 

         (ii)  Adding
the following clause (v) after the first paragraph of Section 2.05(b)(iv): 

        "(v)
Subject to the first two sentences of this subsection (b), upon any tax refund received by or paid to or for the account of either Borrower or any of their Subsidiaries for
fiscal year 2007 and all prior years, the Borrowers shall prepay an aggregate principal amount of the Term Loans equal to 50% of such tax refund (net of reasonable and 

4

 

customary
expenses associated therewith in an aggregate amount not to exceed $25,000) on (A) the later of October 1, 2008 or ten (10) days following the receipt thereof with
respect to all such tax refunds received on or prior to October 1, 2008, (B) on the later of January 1, 2009 or ten (10) days following the receipt thereof with respect to
all such tax refunds received after October 1, 2008 and on or prior to January 1, 2009, (C) on the later of April 1, 2009 or ten (10) days following the receipt
thereof with respect to all such tax refunds received after January 1, 2009 and on or prior to April 1, 2009, and (D) within ten (10) days of receipt of any such tax refund
received after April 1, 2009." 

        (iii)  Renumbering
original clause "(v)" to clause "(vi)". 

        (m)  Section 5.05(e) of the Second Lien Credit Agreement is hereby amended by replacing the reference therein to
"Section 6.01(d)" with "Sections 6.01(d) and  (e)". 

        (n)   Section 6.01 of the Second Lien Credit Agreement is hereby amended by amending and restating  Sections 6.01(b), (c) and (d) in their entirety
and adding a new Section 6.01(e), each to read as follows: 

        "(b)
as soon as available, but in any event within 45 days after the end of each of the first three fiscal quarters of each fiscal year of Holdings (commencing with the fiscal
quarter ended June 30, 2007), a consolidated and consolidating balance sheet of Holdings and its Subsidiaries as of the end of such fiscal quarter, and the related consolidated and
consolidating statements of income or operations, shareholders' equity and cash flows for such fiscal quarter and for the portion of Holdings' fiscal year then ended, setting forth in each case in
comparative form the figures for (i) the corresponding fiscal quarter of the previous fiscal year and the corresponding portion of the previous fiscal year and (ii) the corresponding
fiscal quarter and corresponding portion of the fiscal year set forth in the annual business plan and budget delivered for such fiscal year, all in reasonable detail, such consolidated statements to
be certified by the chief executive officer, chief financial officer, treasurer or controller of Holdings as fairly presenting the financial condition, results of operations, shareholders' equity and
cash flows of Holdings and its Subsidiaries in accordance with GAAP, subject only to normal year-end audit adjustments and the absence of footnotes and explaining in writing any variances
from the annual business plan and budget of 10% or more;" 

        "(c)
as soon as available, but in any event within 30 days after the end of each of the first 11 months of each fiscal year of Holdings (commencing with the fiscal month
ended June 30, 2007), a consolidated and consolidating balance sheet of Holdings and its Subsidiaries as of the end of such month, and the related consolidated and consolidating statements of
income or operations, shareholders' equity and cash flows for such month and for the portion of Holdings' fiscal year then ended setting forth in each case in comparative form the figures (i)
for the corresponding month of the previous fiscal year and the corresponding portion of the previous fiscal year and (ii) the corresponding month and corresponding portion of the fiscal year
set forth in the annual business plan and budget delivered for such fiscal year, all in reasonable detail, duly certified by the chief executive officer, chief financial officer, treasurer or
controller of Holdings and with any variances from the annual business plan and budget of 10% or more explained in writing by management;" 

        "(d)
as soon as available, but in any event at least 15 days before the beginning of each fiscal year of Holdings, an assumption-driven annual business plan and budget of the
Borrowers and their respective Subsidiaries on a consolidated and consolidating basis, including (i) a financial (cash flow) budget (i.e., a schedule of anticipated revenue and
expenditures) prepared on a monthly basis for the immediately following fiscal year (including the fiscal year in which the Maturity Date for the Term Facility occurs), (ii) a projected EBITDA
run rate and (iii) a written assessment by management of the run-rate revenue and 

5

 

run-rate
EBITDA by business line, all in form satisfactory to the Administrative Agent and the Required Lenders; and" 

        "(e)
for the first twelve (12) months following the Second Amendment Effective Date (as such period may be reduced or extended by the Required Lenders), on a bi-weekly
basis, a rolling thirteen-week financial (cash-flow) budget (schedule of anticipated revenue and expenditures) together with a schedule that shows a projected versus actual
comparison of the items set forth in the budget over the course of (i) the preceding two weeks and (ii) the period beginning March 3, 2008." 

        (o)   Sections 6.02(b) and (c) of the Second Lien Credit Agreement are
hereby amended by (i) inserting the words "and (c)" following the clause "referred to in  Sections 6.01(a) and (b)
" in  Section 6.02(b) and (ii) amending and restating Section 6.02(c) in its entirety as
follows: 

        "(c)
within thirty (30) days following the end of each calendar month, a certificate, substantially in the form of  Exhibit E, signed by the chief executive officer, the chief financial officer,
treasurer or controller of Holdings certifying as to the Loan
Parties' (i) current consolidated Membership for such month, (ii) setting forth the number of senior members separate from the number of commercial members for such month,
(iii) comparing such Membership data to the Membership data provided for the immediately preceding month; and (iv) explaining any material variances noted within the comparison
(i.e., a summary of any terminations of existing contracts in connection with the Membership during the period covered by such certificate and its effect on Membership)." 

        (p)   Section 6.03(f) of the Second Lien Credit Agreement is amended by (i) replacing the "and" immediately prior
to clause (iii) therein with a "," and (ii) adding the following clause (iv) to the end of such section: "and (iv) receipt of any tax refund for which either Borrower is
required to make a mandatory prepayment pursuant to Section 2.05(b)(v)". 

        (q)   Sections 7.11 of the Second Lien Credit Agreement is hereby amended by amending and restating  Sections 7.11(a) and (b) in their entirety, deleting the current  Section 7.11(c) and substituting in lieu thereof a new Section 7.11(c), each to read as
follows: 

        "(a)
Consolidated Leverage Ratio.    From April 30, 2008 through and including June 30, 2009, permit the
Consolidated Leverage Ratio as of any month end to be greater than the ratio set forth below opposite such period, and commencing July 1, 2009, permit the 

6

 

Consolidated
Leverage Ratio as of any quarter end to be greater than the ratio set forth below opposite such period: 

					
	Period

 
	 	Maximum Consolidated

Leverage Ratio 	 
	 Twelve-month period ending April 30, 2008
	 	 	5.35 to 1.00	 
	 Twelve-month period ending May 31, 2008
	 	 	7.40 to 1.00	 
	 Twelve-month period ending June 30, 2008
	 	 	6.80 to 1.00	 
	 Twelve-month period ending July 31, 2008
	 	 	6.45 to 1.00	 
	 Twelve-month period ending August 31, 2008
	 	 	6.25 to 1.00	 
	 Twelve-month period ending September 30, 2008
	 	 	5.55 to 1.00	 
	 Twelve-month period ending October 31, 2008
	 	 	5.50 to 1.00	 
	 Twelve-month period ending November 30, 2008
	 	 	5.45 to 1.00	 
	 Twelve-month period ending December 31, 2008
	 	 	5.40 to 1.00	 
	 Twelve-month period ending January 31, 2009
	 	 	5.20 to 1.00	 
	 Twelve-month period ending February 28, 2009
	 	 	5.10 to 1.00	 
	 Twelve-month period ending March 31, 2009
	 	 	4.95 to 1.00	 
	 Twelve-month period ending April 30, 2009
	 	 	4.75 to 1.00	 
	 Twelve-month period ending May 31, 2009
	 	 	4.35 to 1.00	 
	 Twelve-month period ending June 30, 2009
	 	 	4.15 to 1.00	 
	 Four fiscal quarters ending September 30, 2009
	 	 	4.00 to 1.00	 
	 Four fiscal quarters ending December 31, 2009
	 	 	3.75 to 1.00	 
	 Four fiscal quarters ending March 31, 2010
	 	 	3.65 to 1.00	 
	 Four fiscal quarters ending June 30, 2010 and each period of four fiscal quarters ending thereafter
	 	 	3.55 to 1.00"	 

        "(b)
Consolidated Fixed Charge Coverage Ratio.    From April 30, 2008 through and including June 30, 2009, permit
the Consolidated Fixed Charge Coverage Ratio as of any month end to be less than the ratio set forth below opposite such period, and commencing July 1, 2009, permit the 

7

 

Consolidated
Fixed Charge Coverage Ratio as of any quarter end to be less than the ratio set forth below opposite such period: 

					
	Period

 
	 	Minimum Fixed Charge

Coverage Ratio 	 
	 Twelve-month period ending April 30, 2008
	 	 	0.900 to 1.00	 
	 Twelve-month period ending May 31, 2008
	 	 	0.600 to 1.00	 
	 Twelve-month period ending June 30, 2008
	 	 	0.575 to 1.00	 
	 Twelve-month period ending July 31, 2008
	 	 	0.600 to 1.00	 
	 Twelve-month period ending August 31, 2008
	 	 	0.650 to 1.00	 
	 Twelve-month period ending September 30, 2008
	 	 	0.725 to 1.00	 
	 Twelve-month period ending October 31, 2008
	 	 	0.725 to 1.00	 
	 Twelve-month period ending November 30, 2008
	 	 	0.750 to 1.00	 
	 Twelve-month period ending December 31, 2008
	 	 	0.450 to 1.00	 
	 Twelve-month period ending January 31, 2009
	 	 	0.475 to 1.00	 
	 Twelve-month period ending February 28, 2009
	 	 	0.500 to 1.00	 
	 Twelve-month period ending March 31, 2009
	 	 	0.525 to 1.00	 
	 Twelve-month period ending April 30, 2009
	 	 	0.575 to 1.00	 
	 Twelve-month period ending May 31, 2009
	 	 	0.700 to 1.00	 
	 Twelve-month period ending June 30, 2009
	 	 	0.725 to 1.00	 
	 Four fiscal quarters ending September 30, 2009
	 	 	0.825 to 1.00	 
	 Four fiscal quarters ending December 31, 2009
	 	 	0.800 to 1.00	 
	 Four fiscal quarters ending March 31, 2010
	 	 	0.800 to 1.00	 
	 Four fiscal quarters ending June 30, 2010 and each period of four fiscal quarters ending thereafter
	 	 	0.850 to 1.00"	 

        "(c)
Minimum Consolidated EBITDA.    From April 30, 2008 through and including June 30, 2009, permit Consolidated
EBITDA as of any month end to be less than the amount set forth below opposite 

8

 

such
period, and commencing July 1, 2009, permit Consolidated EBITDA as of any quarter end to be less than the amount set forth below opposite such period: 

					
	Period

 
	 	Minimum Consolidated

EBITDA 	 
	 Twelve-month period ending April 30, 2008
	 	$	27,000,000	 
	 Twelve-month period ending May 31, 2008
	 	$	20,500,000	 
	 Twelve-month period ending June 30, 2008
	 	$	21,500,000	 
	 Twelve-month period ending July 31, 2008
	 	$	22,500,000	 
	 Twelve-month period ending August 31, 2008
	 	$	23,000,000	 
	 Twelve-month period ending September 30, 2008
	 	$	26,000,000	 
	 Twelve-month period ending October 31, 2008
	 	$	26,000,000	 
	 Twelve-month period ending November 30, 2008
	 	$	26,500,000	 
	 Twelve-month period ending December 31, 2008
	 	$	16,750,000	 
	 Twelve-month period ending January 31, 2009
	 	$	17,500,000	 
	 Twelve-month period ending February 28, 2009
	 	$	18,000,000	 
	 Twelve-month period ending March 31, 2009
	 	$	18,500,000	 
	 Twelve-month period ending April 30, 2009
	 	$	19,250,000	 
	 Twelve-month period ending May 31, 2009
	 	$	21,250,000	 
	 Twelve-month period ending June 30, 2009
	 	$	22,000,000	 
	 Four fiscal quarters ending September 30, 2009
	 	$	23,000,000	 
	 Four fiscal quarters ending December 31, 2009
	 	$	24,000,000	 
	 Four fiscal quarters ending March 31, 2010
	 	$	24,500,000	 
	 Four fiscal quarters ending June 30, 2010 and each period of four fiscal quarters ending thereafter
	 	$	25,500,000"	 

9

 

 

        (r)   Exhibits C and E of the Second Lien Credit Agreement are hereby
amended and restated in their entirety by replacing the existing Exhibits C and E with the new
exhibits attached hereto as Exhibit A. 

        4.     Effectiveness; Conditions Precedent.    This Agreement shall be effective when all of the conditions set forth
in this Section shall have been satisfied in form and substance satisfactory to the Second Lien Administrative Agent. 

        (a)   The
Second Lien Administrative Agent shall have received duly executed counterparts of this Agreement from each of the Borrowers, the Guarantors, the Second Lien
Administrative Agent and the Second Lien Lenders. 

        (b)   The
Borrowers shall have paid all professional fees and expenses of the Second Lien Administrative Agent and the Second Lien Lenders in connection with this Agreement,
the Loan Documents and the transactions contemplated hereby (including all fees and expenses of Winston & Strawn LLP in its capacity as counsel to the Second Lien Administrative Agent
and all fees and expenses of Alvarez & Marsal) pursuant to wire transfer instructions to be provided by the Second Lien Administrative Agent. 

        (c)   The
Second Lien Administrative Agent shall have received a corresponding amendment to the First Lien Credit Agreement, in form and substance substantially consistent
with this Agreement (with such changes as are applicable only to the First Lien Credit Agreement), duly executed by the First Lien Administrative Agent, the Borrowers, each Guarantor and the First
Lien Lenders. 

        (d)   The
Borrowers shall be in compliance with their obligations under that certain fee letter among the Borrowers, Banc of America Securities, LLC and Bank of
America, N.A. dated January 28, 2008 (as amended by that certain amendment thereto as of the date hereof, the "Amendment Fee Letter"). 

        (e)   The
Second Lien Administrative Agent shall have received a duly executed amendment to the Fee Letter in form and substance satisfactory to the Second Lien Administrative
Agent. 

        (f)    In
addition to any amounts previously paid or owing to the Second Lien Lenders, the Borrowers shall have paid an amendment fee in an amount equal to: (i) 50 basis
points times the aggregate outstanding principal amount of each consenting Second Lien Lender's Term Loans to the Borrowers (in each case,
(x) including Bank of America, N.A., in its capacity as a Second Lien Lender, and (y) as of the effective date of this Agreement) to be paid in cash on the effective date of this
Amendment plus (ii) 100 basis points times the aggregate outstanding principal amount of each
consenting Second Lien Lender's Term Loans to the Borrowers (in each case, (x) including Bank of America, N.A., in its capacity as a Second Lien Lender, and (y) as of the effective date
of this Agreement) to be paid in kind by adding such 100 basis fee amount to the outstanding principal of the Term Loans on the effective date of this Amendment. 

        (g)   The
Revolving Loan Account (as such term is defined in the First Lien Credit Agreement, the "Revolving Loan Account")
shall have been established and such account shall be subject to the existing deposit account control agreement (with such supplements and amendments as may be necessary or desirable) perfecting the
Administrative Agent's security interest (for the benefit of the Secured Parties) in PMG's Deposit Accounts (including the Revolving Loan Account) and otherwise in accordance with the Collateral
Agreement prior to the disbursement thereinto of the proceeds from any Revolving Credit Loan (as such term is defined in the First Lien Credit Agreement). 

        (h)   The
Second Lien Administrative Agent shall have received a favorable opinion of Theodora Oringher Miller and Richman PC, counsel to the Loan Parties, addressed to the
Second 

10

 

Lien
Administrative Agent and each Second Lien Lender, as to such matters concerning the Loan Parties and the Loan Documents as the Second Lien Administrative Agent or the Required Lenders may
reasonably request. 

        (i)    The
Second Lien Administrative Agent shall have received a duly executed side letter from the Borrowers in form and substance satisfactory to the Second Lien
Administrative Agent. 

        (j)    The
Second Lien Administrative Agent shall have received an amendment to that certain Deposit Account Control Agreement dated as of October 10, 2007 (the
"DACA") among Prospect Medical Holdings, Inc., Prospect Medical Group, Inc., Prospect Medical Systems, Inc., ProMed Health Care
Administrators, Pomona Valley Medical Group, Inc., Upland Medical Group, Professional Medical Corporation, the First Lien Administrative Agent, the Second Lien Administrative Agent and Bank of
America, N.A., as depository bank, adding the Revolving Loan Account as an Account (as defined in the DACA) under the DACA. 

        (k)   The
Second Lien Administrative Agent shall have received such other instruments, documents and certificates as the Second Lien Administrative Agent shall reasonably
request in connection with the execution of this Agreement. 

        5.     Other Agreements. 

        (a)   The
Borrowers shall use commercially reasonable efforts to deliver a landlord estoppel and consent agreement with respect to that certain Standard Office Lease dated as
of April 16, 2008 between AG/CAMBRA 10780 Santa Monica Owner, L.L.C. and Alta Hospitals System, LLC, in form and substance satisfactory to the Second Lien Administrative Agent and within
sixty (60) days following the Second Amendment Effective Date. Failure to comply with the foregoing covenant will be deemed an immediate Event of Default. 

        (b)   The
items set forth on Schedule B hereto shall be delivered to the Second Lien Administrative Agent and the Second
Lien Lenders on the earlier of (a) the corresponding date set forth on Schedule B hereto and (b) the date each such item is
required to be delivered pursuant to the requirements of American Stock Exchange ("AMEX") and the SEC (after giving effect to any waivers of compliance
and extensions provided and confirmed by AMEX and/or the SEC). Failure to comply with the foregoing covenant will be deemed an immediate Event of Default. 

        (c)   No
later than May 28, 2008 (unless such time period is extended by the Second Lien Administrative Agent and the Required Lenders in their reasonable discretion),
the Borrowers shall have delivered to the Second Lien Administrative Agent and the Second Lien Lenders revised compliance packages (including revised Compliance Certificates) for the fiscal year ended
September 30, 2007 and the fiscal quarter ended December 31, 2007. Failure to comply with the foregoing covenant will be deemed an immediate Event of Default. 

        6.     Representations and Warranties.    Each Loan Party hereby represents and warrants to the Second Lien
Administrative Agent and the Second Lien Lenders that (a) each Loan Party has the legal power and authority to execute and deliver this Agreement; (b) the officers of each Loan Party
executing this Agreement have been duly authorized to execute and deliver the same and bind each Loan Party with respect to the provisions hereof; (c) the execution and delivery hereof by each
Loan Party and the performance and observance by each Loan Party of the provisions hereof do not violate or conflict with any organizational document of any Loan Party or any law applicable to any
Loan Party or result in a breach of any provision of or constitute a default under any other agreement, instrument or document binding upon or enforceable against any Loan Party; (d) after
giving effect to the waivers set forth in Section 1 above, no Default or Event of Default exists under the Second Lien Credit Agreement, nor will
any occur immediately after the execution and delivery of this Agreement or by the performance or observance of any provision hereof; (e) no Loan Party is aware of any claim 

11

 

or
offset against, or defense or counterclaim to, any Loan Party's obligations or liabilities under the Second Lien Credit Agreement or any other Loan Document; (f) this Agreement and each
document executed by each Loan Party in connection herewith (including, without limitation, the Amendment Fee Letter) constitute valid and binding obligations of the applicable Loan Party in every
respect, enforceable in accordance with their terms; (g) no Loan Party has received a notice of default of any kind from any material account debtor or any counterparty to a Material Contract
and no material account debtor or counterparty to a Material Contract has asserted any right of set-off, deduction or counterclaim with respect to any account or such Material Contract,
respectively and (h) all representations and warranties made by each Borrower and contained in this Agreement, the Second Lien Credit Agreement or any other Loan Document to which it is a party
are true and correct in all material respects on and as of the date of this Agreement to the same extent as though made on and as of such date, except to the extent that any thereof expressly relate
to an earlier date. 

        7.     Release.    Each Loan Party hereby waives and releases the Second Lien Administrative Agent, each Second Lien
Lender and their respective directors, officers, employees, agents, attorneys, affiliates and subsidiaries (each a "Releasee") from any and all claims,
offsets, defenses and counterclaims, known and unknown, that any Loan Party may have as of the date of this Agreement based upon, relating to, or arising out of the Obligations and related
transactions in any way. Each Loan Party intends the foregoing release to cover, encompass, release and extinguish, among other things, all claims and matters that might otherwise be reserved by
California Civil Code Section 1542, which provides as follows: 

"A
general release does not extend to claims which the creditor does not know or suspect to exist in his or her favor at the time of executing the release, which if known by him or her must have
materially affected his or her settlement with the debtor." 

Notwithstanding
the foregoing, this Section 7 shall not constitute a release of the obligations of the Second Lien Administrative Agent or any
Second Lien Lender under the Loan Documents, such waiver and release being with full knowledge and understanding of the circumstances and effect thereof and after having consulted legal counsel with
respect thereto. 

        8.     Covenant Not to Sue.    Each Loan Party, on behalf of itself and its successors, assigns, and other legal
representatives, hereby absolutely, unconditionally and irrevocably, covenants and agrees with and in favor of each Releasee that it will not sue (at law, in equity, in any regulatory proceeding or
otherwise) any Releasee on the basis of any claim released, remised and discharged by such Loan Party pursuant to Section 7 above. If any Loan
Party or any of its successors, assigns or other legal representations violates the foregoing covenant, such Loan Party, for itself and its successors, assigns and legal representatives, agrees to
pay, in addition to such other damages as any Releasee may sustain as a result of such violation, all attorneys' fees and costs incurred by any Releasee as a result of such violation. 

        9.     Loan Documents Unaffected.    Except as otherwise specifically provided herein, all provisions of the Second
Lien Credit Agreement (including without limitation, Section 10.07 thereof) and the other Loan Documents (including, without limitation, the
Intercreditor Agreement) shall remain in full force and effect and be unaffected hereby. The parties hereto acknowledge and agree that this Agreement constitutes a "Loan Document" under the terms of
the Second Lien Credit Agreement. 

        10.   Guarantor Acknowledgement.    Each Guarantor, by signing this Agreement: 

        (a)   Consents
and agrees to and acknowledges the terms of this Agreement, including, without limitation, the amendments to the Second Lien Credit Agreement set forth herein. 

        (b)   Acknowledges
and agrees that all of the Loan Documents to which such Guarantor is a party or otherwise bound shall continue in full force and effect and that all of such
Guarantor's 

12

 

obligations
thereunder shall be valid and enforceable and shall not be impaired or limited by the execution or effectiveness of this Agreement. 

        (c)   Represents
and warrants to the Second Lien Administrative Agent and the Second Lien Lenders that, after giving effect to the waivers set forth in  Section 1 hereof, all representations and warranties made by
such Guarantor and contained in this Agreement or any other Loan Document to which
it is a party are true and correct in all material respects on and as of the date of this Agreement to the same extent as though made on and as of such date, except to the extent that any thereof
expressly relate to an earlier date. 

        (d)   Acknowledges
and agrees that (i) notwithstanding the conditions to effectiveness set forth in this Agreement, such Guarantor is not required by the terms of the
Second Lien Credit Agreement or any other Loan Document to which such Guarantor is a party to consent to the terms of this Agreement
and (ii) nothing in the Second Lien Credit Agreement, this Agreement or any other Loan Document shall be deemed to require the consent of such Guarantor to any future amendments or
modifications to the Second Lien Credit Agreement. 

        11.   No Other Promises or Inducements.    There are no promises or inducements that have been made to any party
hereto to cause such party to enter into this Agreement other than those that are set forth in this Agreement. This Agreement has been entered into by each Borrower and each Guarantor freely,
voluntarily, with full knowledge, and without duress, and, in executing this Agreement, neither any Borrower nor any Guarantor is relying on any other representations, either written or oral, express
or implied, made to any Borrower or any Guarantor by the Second Lien Administrative Agent. Each Borrower and each Guarantor agrees that the consideration received by the Borrowers under this Agreement
has been actual and adequate. 

        12.   No Course of Dealing.    Each Loan Party acknowledges and agrees that, (a) this Agreement is not
intended to, nor shall it, establish any course of dealing between the Loan Parties, the Second Lien Administrative Agent and the Second Lien Lenders that is inconsistent with the express terms of the
Second Lien Credit Agreement or any other Loan Document, (b) notwithstanding any course of dealing between the Loan Parties, the Second Lien Administrative Agent and the Second Lien Lenders
prior to the date hereof, except as set forth herein, the Second Lien Lenders shall not be obligated to make any Loan, except in accordance with the terms and conditions of this Agreement and the
Second Lien Credit Agreement, and (c) except with respect to the limited waiver granted herein specifically relating to the Existing Events of Default, neither the Second Lien Administrative
Agent nor any Second Lien Lender shall be under any obligation to forbear from exercising any of its rights or remedies upon the occurrence of any Default or Event of Default. Nothing herein modifies
the agreements among the Second Lien Administrative Agent and the Second Lien Lenders with respect to the exercise of their respective rights and remedies under the terms of the Second Lien Credit
Agreement. 

        13.   No Waiver.    Each Loan Party acknowledges and agrees that (a) except as expressly provided in  Section 1, this Agreement shall not operate
as a waiver of any right, power or remedy of the Second Lien Administrative Agent or the Second Lien
Lenders under the Second Lien Credit Agreement or any Loan Document, nor shall it constitute a continuing waiver at any time and (b) nothing herein shall be deemed to constitute a waiver of any
Default or Event of Default, other than with respect to the Existing Events of Default, and, except as expressly provided herein, nothing herein shall in any way prejudice the rights and remedies of
the Second Lien Administrative Agent or the Second Lien Lenders under the Second Lien Credit Agreement, any Loan Document or applicable law. In addition, the Second Lien Administrative Agent shall
have the right to waive any condition or conditions set forth in this Agreement, the Second Lien Credit Agreement or any Loan Document, in its sole discretion, and any such waiver shall not prejudice,
waive or reduce any other right or remedy that the Second Lien Administrative Agent may have against any Loan Party. 

13

 

        14.   Governing Law.    THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE
WITH, THE LAWS OF THE STATE OF NEW YORK.

        15.   Entire Agreement.    This Agreement (together with the Amendment Fee Letter) sets forth the entire agreement
and understanding among the parties as to the subject matter hereof and merges and supersedes all prior discussions, agreements, and undertakings of every kind and nature among them with respect to
the subject matter hereof. 

        16.   Counterparts.    This Agreement may be executed in any number of counterparts, and by the parties hereto on the
same or separate counterparts and by facsimile signature, and each such counterpart, when executed and delivered, shall be deemed to be an original, but all such counterparts shall together constitute
but one and the same Agreement. 

        17.   Successors and Assigns.    The provisions of this Agreement shall be binding upon and inure to the benefit of
the parties hereto and their respective successors and assigned in accordance with Section 10.06 of the Second Lien Credit Agreement. 

        18.   Severability Of Provisions; Captions; Attachments.    Wherever possible each provision of this Agreement shall
be interpreted in such manner as to be effective and valid under applicable law. Any provision of this Agreement that is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction,
be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining provisions hereof or affecting the validity or enforceability of such provision in any other
jurisdiction. The captions to Sections and subsections herein are inserted for convenience only and shall be ignored in interpreting the provisions of this Agreement. Each schedule or exhibit attached
to this Agreement shall be incorporated herein and shall be deemed to be a part hereof. 

        19.   JURY TRIAL WAIVER.    EACH OF THE UNDERSIGNED, TO THE EXTENT PERMITTED BY LAW, HEREBY WAIVE ANY RIGHT TO HAVE A
JURY PARTICIPATE IN RESOLVING ANY DISPUTE WHETHER SOUNDING IN CONTRACT, TORT, OR OTHERWISE, AMONG THEM, OR ANY OF THEM, ARISING OUT OF, IN CONNECTION WITH, RELATED TO OR INCIDENTAL TO THE RELATIONSHIP
ESTABLISHED AMONG THEM IN CONNECTION WITH THIS AGREEMENT OR ANY DOCUMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED THERETO. 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK] 

14

  
        IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date referenced in the first paragraph of this Agreement. 

							
	Accepted and Agreed:	 	 	 	 
	    	 	 	 	 	 	 
	PROSPECT MEDICAL HOLDINGS, INC.	 	PROSPECT MEDICAL GROUP, INC.
	    	 	 	 	 	 	 
	By:	 	 

	 	By:	 	  

	Name:	 	Samuel S. Lee	 	Name:	 	Jacob Y. Terner, M.D.
	Title:	 	Chief Executive Officer	 	Title:	 	Chief Executive Officer
	    	 	 	 	 	 	 
	ALTA HOSPITALS SYSTEM, LLC, formerly known as PROSPECT HOSPITALS SYSTEM, LLC	 	NUESTRA FAMILIA MEDICAL GROUP, INC.
	    	 	 	 	 	 	 
	By:	 	 

	 	By:	 	  

	Name:	 	Samuel S. Lee	 	Name:	 	Jacob Y. Terner, M.D.
	Title:	 	Manager	 	Title:	 	Secretary
	    	 	 	 	 	 	 
	PROMED HEALTH CARE ADMINISTRATORS

PROMED HEALTH SERVICES COMPANY	 	SIERRA MEDICAL MANAGEMENT, INC.

PROSPECT ADVANTAGE NETWORK, INC.

PINNACLE HEALTH RESOURCES

PROSPECT HOSPITAL ADVISORY SERVICES, INC.
	    	 	 	 	 	 	 
	By:	 	 

	 	By:	 	  

	Name:	 	Samuel S. Lee	 	Name:	 	Samuel S. Lee
	Title:	 	Vice President	 	Title:	 	President and Chief Executive Officer
	    	 	 	 	 	 	 
	POMONA VALLEY MEDICAL GROUP, INC.

UPLAND MEDICAL GROUP, A PROFESSIONAL MEDICAL CORPORATION	 	 	 	 
	    	 	 	 	 	 	 
	By:	 	  

	 	    	 	 
	 
	 	 
	 	

 

	Name:	 	Jacob Y. Terner, M.D.	 	Jacob Y. Terner, M.D., solely in his capacity
	Title:	 	Vice President	 	as Pledgor
	    	 	 	 	 	 	 

	ALTA LOS ANGELES HOSPITALS, INC.

ALTA HOLLYWOOD HOSPITALS, INC.	 	PROSPECT MEDICAL SYSTEMS, INC.
	    	 	 	 	 	 	 
	By:	 	  

	 	By:	 	 

	Name:	 	David Topper	 	Name:	 	Samuel S. Lee
	Title:	 	Chief Executive Officer	 	Title:	 	Chairman of the Board
	    	 	 	 	 	 	 
	PROSPECT MEDICAL GROUP, INC.

SANTA ANA/TUSTIN PHYSICIANS GROUP, INC.

PEGASUS MEDICAL GROUP, INC.

ANTELOPE VALLEY MEDICAL ASSOCIATES, INC.

SIERRA PRIMARY CARE MEDICAL GROUP, A MEDICAL CORPORATION

PROSPECT HEALTH SOURCE MEDICAL GROUP, INC.

PROSPECT PROFESSIONAL CARE MEDICAL GROUP, INC.

PROSPECT NWOC MEDICAL GROUP, INC.

APAC MEDICAL GROUP, INC.

STARCARE MEDICAL GROUP, INC.

GENESIS HEALTHCARE OF SOUTHERN CALIFORNIA, INC., A MEDICAL GROUP PROSPECT PHYSICIAN ASSOCIATES, INC.	 	 	 	 
	    	 	 	 	 	 	 
	By:	 	  

	 	 	 	 
	Name:	 	Jacob Y. Terner, M.D.	 	 	 	 
	Title:	 	Chief Executive Officer	 	 	 	 

					
	
	 	BANK OF AMERICA, N.A., in its capacity as Second Lien Administrative Agent
	    
	 	 	 	 
	
	 	By:	 	 

	
	 	Name:	 	  

	
	 	Title:	 	 

					
	
	 	BANK OF AMERICA, N.A., as a Second Lien Lender, L/C Issuer and Swing Line Lender
	    
	 	 	 	 
	
	 	By:	 	 

	
	 	Name:	 	  

	
	 	Title:	 	 

  Schedule A  

 EXISTING EVENTS OF DEFAULT

        1.     Failure
of the Borrowers to deliver by January 28, 2008 to the Second Lien Administrative Agent and the Second Lien Lenders the financial statements and other
reports and information required under Section 6.01(a) of the Second Lien Credit Agreement (Event of Default under  Section 8.01(b) of the Second
Lien Credit Agreement). 

        2.     Failure
of the Borrowers to deliver by January 28, 2008 to the Second Lien Administrative Agent and the Second Lien Lenders the accountants certificate and the
Compliance Certificate required under Sections 6.02(a) and (b) of the Second Lien Credit
Agreement (Events of Default under Section 8.01(b) of the Second Lien Credit Agreement). 

        3.     Failure
of the Borrowers to deliver by February 14, 2008 to the Second Lien Administrative Agent and the Second Lien Lenders the financial statements and other
reports and information required under Section 6.01(b) of the Second Lien Credit Agreement (Event of Default under  Section 8.01(b) of the Second
Lien Credit Agreement). 

        4.     Failure
of the Borrowers to deliver by February 14, 2008 to the Second Lien Administrative Agent and the Second Lien Lenders the Compliance Certificate required
under Section 6.02(b) of the Second Lien Credit Agreement (Events of Default under  Section 8.01(b) of the Second Lien Credit Agreement).

        5.     Failure
of the Borrowers to comply with the financial covenant set forth in Section 7.11(a) of the Second Lien
Credit Agreement (Events of Default under Section 8.01(b) of the Second Lien Credit Agreement) for the fiscal year ended September 30,
2007. 

        6.     Failure
of the Borrowers to comply with the financial covenants set forth in Section 7.11(a) and  Section 7.11(b) of the Second Lien Credit Agreement
(Events of Default under  Section 8.01(b) of the Second Lien Credit Agreement) for the fiscal quarter ended December 31, 2007. 

        7.     Failure
of the Borrowers to comply with the financial covenants set forth in Section 7.11(a) of the Second Lien
Credit Agreement (Events of Default under Section 8.01(b) of the Second Lien Credit Agreement) for the fiscal quarter ended March 31,
2008. 

        8.     Event
of Default under Section 8.01(e) resulting from a cross default under the Second Lien Credit Agreement with
respect to the Borrowers' Swap Contract hedging interest rate exposure for the Term Loans. 

        9.     Failure
of the Borrowers to comply with the affirmative covenants set forth in Sections 6.02(e) (delivery of
proxy), 6.02(g) (summary of insurance coverage), 6.02(m) (quarterly reports on Capitated Contracts),  6.02(n)
(monthly claims lag analysis) and 6.02(o) (Actuarial Reports) through the date hereof of the
Second Lien Credit Agreement (Events of Default under Section 8.01(b) of the Second Lien Credit Agreement). 

        10.   Failure
of the Borrowers to comply with the affirmative covenant set forth in Section 6.03(g) (disclosure of Debt
Ratings change or possible change) of the Second Lien Credit Agreement (Event of Default under Section 8.01(b) of the Second Lien Credit
Agreement). 

        11.   Failure
of Holdings, Prospect Hospital Advisory Services, Inc., Prospect Medical Systems, Inc. and Sierra Medical Management, Inc. to maintain good
standing as required under Section 6.05(a) of the Second Lien Credit Agreement (Event of Default under  Section 8.01(b) of the Second Lien Credit
Agreement) (such entities have renewed good standing under their respective jurisdictions of
organization as of the date of this Agreement). 

 Schedule B  

 AMEX COMPLIANCE ITEMS  

        1.     File 2007
10-K by June 16, 2008 (with unqualified accountants' letter) 

        2.     File 10-Q
for the quarter ended December 31, 2007 by June 16, 2008 

        3.     File 10-Q
for the quarter ended March 31, 2008 by June 16, 2008 

  Exhibit A  

 TO SECOND AMENDMENT TO SECOND LIEN CREDIT AGREEMENT, WAIVER AND CONSENT  

 EXHIBIT C  

 FORM OF COMPLIANCE CERTIFICATE  

Financial
Statement Date:                        ,        

	To:
	Bank
of America, N.A., as Administrative Agent 

Ladies
and Gentlemen: 

        Reference
is made to that certain Second Lien Credit Agreement, dated as of August 8, 2007 (as amended, restated, extended, supplemented or otherwise modified in writing from time
to time, the "Agreement"), among Prospect Medical Holdings, Inc., a Delaware corporation
("Holdings"), Prospect Medical Group, Inc., a California professional corporation (collectively with Holdings, the
"Borrowers"), the Lenders from time to time party thereto, and Bank of America, N.A., as Administrative Agent. Capitalized terms used herein and not
defined herein shall have the meanings assigned thereto in the Agreement. 

        The
undersigned Responsible Officer(1) hereby certifies as of the date hereof that he/she is the
                                     of Holdings,
and that, as such, he/she is authorized to execute and deliver this Certificate to the Administrative Agent on the behalf of the Borrowers, and that: 

[Use following paragraph 1 for fiscal year-end financial statements]

        1.     The
Borrowers have delivered (i) the year-end audited financial statements required by  Section 6.01(a) of the Agreement for the fiscal year of Holdings ended as of the above date, together with
the report and opinion of an
independent certified public accountant required by such section and (ii) the consolidated and consolidating balance sheet of Holdings and its Subsidiaries as at the end of such fiscal year and
the related consolidated and consolidating statements of income or operations, shareholders' equity and cash flows for such fiscal year, setting forth in each case in comparative form the figures for
the previous fiscal year. 

[Use following paragraph 1 for fiscal quarter-end financial statements]

        1.     The
Borrowers have delivered the unaudited financial statements required by Section 6.01(b) of the Agreement for
the fiscal quarter of Holdings ended as of the above date. Such consolidated and consolidating financial statements fairly present the financial condition, results of operations shareholders' equity
and cash flows of Holdings and its Subsidiaries in accordance with GAAP as at such date and for such period, subject only to normal year-end audit adjustments and the absence of footnotes. 

[Use following paragraph 1 for fiscal month-end financial statements]

        1.     The
Borrowers have delivered the unaudited financial statements required by Section 6.01(c) of the Agreement for
the fiscal month of Holdings ended as of the above date. Such consolidated and consolidating financial statements fairly present the financial condition, results of operations shareholders' equity and
cash flows of Holdings and its Subsidiaries in accordance with GAAP as at such date and for such period, subject only to normal year-end audit adjustments and the absence of footnotes. 

        2.     The
undersigned has reviewed and is familiar with the terms of the Agreement and has made, or has caused to be made under his/her supervision, a detailed review of the
transactions and condition (financial or otherwise) of Holdings and its Subsidiaries during the accounting period covered by such financial statements.

	(1)
	This
certificate should be from the chief executive officer chief financial officer, treasurer or controller of Holdings. 

        3.     A
review of the activities of the Borrowers during such fiscal period has been made under the supervision of the undersigned with a view to determining whether during
such fiscal period the Borrowers performed and observed all their Obligations under the Loan Documents, and 

[select one:]

        [to
the best knowledge of the undersigned, during such fiscal period the Borrowers performed and observed each covenant and condition of the Loan Documents applicable to
them, and no Default has occurred and is continuing.] 

—or—

        [to
the best knowledge of the undersigned, the following covenants or conditions have not been performed or observed and the following is a list of each such Default and its
nature and status:] 

        4.     The
representations and warranties of the Borrowers contained in Article V of the Agreement and all representations
and warranties of any Loan Party that are contained in any document furnished at any time under or in connection with the Loan Documents, are true and correct on and as of the date hereof, except to
the extent that such representations and warranties specifically refer to an earlier date, in which case they are true and correct as of such earlier date, and except that for purposes of this
Compliance Certificate, the representations and warranties contained in subsections (a) and (b) of Section 5.05 of the Agreement
shall be deemed to refer to the most recent statements furnished pursuant to clauses (a), (b) and (c), respectively, of  Section 6.01 of the Agreement, including the statements in
connection with which this Compliance Certificate is delivered. 

        5.     The
financial covenant analyses and information set forth on Schedules 1 and  2-A through 2-C (as
applicable) attached hereto are true and accurate on and as
of the date of this Certificate. 

        IN WITNESS WHEREOF, the undersigned has executed this Certificate as
of                             ,
                             .
 

					
	
	 	PROSPECT MEDICAL HOLDINGS, INC.
	    
	 	 	 	 
	
	 	By:	 	 

	
	 	Name:	 	  

	
	 	Title:	 	 

For
the Month/Quarter/Year ended                                    
("Statement Date") 

 SCHEDULE 1
  to the Compliance Certificate

($ in 000's) 

									
	 
	 	 
	 	 
	 	 
	 
	I.	 	Section 7.11(a)—Consolidated Leverage Ratio.	 	 	 	 
	A. 	 	Consolidated Total Indebtedness at Statement Date:	 	$	 	 
	B. 	 	Consolidated EBITDA for twelve consecutive months or four consecutive fiscal quarters (as applicable) ending on the Statement Date ("Subject Period") from Schedule 2-A,
2-B or 2-C (as applicable):	 	$	 	 
	C. 	 	Consolidated Leverage Ratio (Line I.A ÷ Line I.B):	 	 	to 1.00	 
	 	 	Maximum Allowed:	 	 	 	 
	 	 	Twelve Calendar Months Ending:	 	 	 	 
	 	 	 	 	 April 30, 2008	 	 	 5.35 to 1.00	 
	 	 	 	 	 May 31, 2008	 	 	 7.40 to 1.00	 
	 	 	 	 	 June 30, 2008	 	 	 6.80 to 1.00	 
	 	 	 	 	 July 31, 2008	 	 	 6.45 to 1.00	 
	 	 	 	 	 August 31, 2008	 	 	 6.25 to 1.00	 
	 	 	 	 	 September 30, 2008	 	 	 5.55 to 1.00	 
	 	 	 	 	 October 31, 2008	 	 	 5.50 to 1.00	 
	 	 	 	 	 November 30, 2008	 	 	 5.45 to 1.00	 
	 	 	 	 	 December 31, 2008	 	 	 5.40 to 1.00	 
	 	 	 	 	 January 31, 2009	 	 	 5.20 to 1.00	 
	 	 	 	 	 February 28, 2009	 	 	 5.10 to 1.00	 
	 	 	 	 	 March 31, 2009	 	 	 4.95 to 1.00	 
	 	 	 	 	 April 30, 2009	 	 	 4.75 to 1.00	 
	 	 	 	 	 May 31, 2009	 	 	 4.35 to 1.00	 
	 	 	 	 	 June 30, 2009	 	 	 4.15 to 1.00	 
	 	 	Four Fiscal Quarters Ending:	 	 	 	 
	 	 	 	 	 September 30, 2009	 	 	 4.00 to 1.00	 
	 	 	 	 	 December 31, 2009	 	 	 3.75 to 1.00	 
	 	 	 	 	 March 31, 2010	 	 	 3.65 to 1.00	 
	 	 	 	 	 June 30, 2010 and each period of four fiscal quarters ending thereafter	 	 	 3.55 to 1.00	 

									
	 
	 	 
	 	 
	 	 
	 
	II.	 	Section 7.11(b)—Consolidated Fixed Charge Coverage Ratio.	 	 	 	 
	A. 	 	Consolidated EBITDA for Subject Period (Line I.B above):	 	$	 	 
	B. 	 	Cash Capital Expenditures for Subject Period:	 	$	 	 
	C. 	 	Consolidated Fixed Charges for Subject Period:	 	 	 	 
	 	 	1.  Consolidated Interest Charges for Subject Period:	 	$	 	 
	 	 	2.  Taxes paid in cash during Subject Period:	 	$	 	 
	 	 	3.  Scheduled and mandatory principal payments with respect to Indebtedness for Subject Period:	 	$	 	 
	 	 	4.  Consolidated Fixed Charges (Lines II.C.1 + II.C.2 + II.C.3):	 	$	 	 
	D. 	 	Consolidated Fixed Charge Coverage Ratio [(Line II.A - Line II.B) ÷ Line II.C.4]:	 	 	to 1.00	 
	 	 	Minimum Required:	 	 	 	 
	 	 	Twelve Calendar Months Ending:	 	 	 	 
	 	 	 	 	 April 30, 2008	 	 	 0.900 to 1.00	 
	 	 	 	 	 May 31, 2008	 	 	 0.600 to 1.00	 
	 	 	 	 	 June 30, 2008	 	 	 0.575 to 1.00	 
	 	 	 	 	 July 31, 2008	 	 	 0.600 to 1.00	 
	 	 	 	 	 August 31, 2008	 	 	 0.650 to 1.00	 
	 	 	 	 	 September 30, 2008	 	 	 0.725 to 1.00	 
	 	 	 	 	 October 31, 2008	 	 	 0.725 to 1.00	 
	 	 	 	 	 November 30, 2008	 	 	 0.750 to 1.00	 
	 	 	 	 	 December 31, 2008	 	 	 0.450 to 1.00	 
	 	 	 	 	 January 31, 2009	 	 	 0.475 to 1.00	 
	 	 	 	 	 February 28, 2009	 	 	 0.500 to 1.00	 
	 	 	 	 	 March 31, 2009	 	 	 0.525 to 1.00	 
	 	 	 	 	 April 30, 2009	 	 	 0.575 to 1.00	 
	 	 	 	 	 May 31, 2009	 	 	 0.700 to 1.00	 
	 	 	 	 	 June 30, 2009	 	 	 0.725 to 1.00	 
	 	 	Four Fiscal Quarters Ending:	 	 	 	 
	 	 	 	 	 September 30, 2009	 	 	 0.825 to 1.00	 
	 	 	 	 	 December 31, 2009	 	 	 0.800 to 1.00	 
	 	 	 	 	 March 31, 2010	 	 	 0.800 to 1.00	 
	 	 	 	 	 June 30, 2010 and each period of four fiscal quarters ending thereafter	 	 	 0.850 to 1.00	 

  
For the Month/Quarter/Year ended                                    
("Statement Date") 

 SCHEDULE 2-A
  to the Compliance Certificate

($ in 000's) 

 Consolidated EBITDA
  (in accordance with the definition of Consolidated EBITDA

as set forth in the Agreement) 

[USE ONLY FOR STATEMENT DATES OCCURRING DURING MONTHLY TESTING PERIODS]

																											
	Consolidated

EBITDA

 
	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Twelve

Months

Ended

 
	 Consolidated Net Income
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + Consolidated Interest Charges
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + income taxes
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + depreciation expense
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + amortization expense
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + non-recurring non-cash expenses
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + add-backs
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 - income tax credits
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 - non-cash income
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 - gains (+ losses) from dispositions of capital assets
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 - extraordinary gains (+ losses) net of related tax effects
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 = Consolidated EBITDA
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
  Minimum Consolidated EBITDA required under Section 7.11(c) (see Annex to Schedule for
determination of Minimum Consolidated EBITDA):
	 	 

For the Quarter/Year
ended                                    ("Statement Date") 

 SCHEDULE 2-B
  to the Compliance Certificate

($ in 000's) 

 Consolidated EBITDA
  (in accordance with the definition of Consolidated EBITDA

as set forth in the Agreement) 

[USE ONLY FOR STATEMENT DATES OCCURRING DURING QUARTERLY TESTING WHERE HISTORICAL MONTHLY FINANCIAL INFORMATION IS USED—DELETE COLUMNS AS
NEEDED]

																											
	Consolidated

EBITDA

 
	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Month

Ended

 	 	Twelve

Months

Ended

 
	 Consolidated Net Income
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + Consolidated Interest Charges
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + income taxes
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + depreciation expense
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + amortization expense
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + non-recurring non-cash expenses
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 + add-backs
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 - income tax credits
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 - non-cash income
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 - gains (+ losses) from dispositions of capital assets
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 - extraordinary gains (+ losses) net of related tax effects
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	 = Consolidated EBITDA
	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 
	
  Minimum Consolidated EBITDA required under Section 7.11(c) (see Annex to Schedule for
determination of Minimum Consolidated EBITDA):
	 	 

For the Quarter/Year
ended                                    ("Statement Date") 

 SCHEDULE 2-C
  to the Compliance Certificate

($ in 000's) 

 Consolidated EBITDA
  (in accordance with the definition of Consolidated EBITDA

as set forth in the Agreement) 

[USE ONLY FOR STATEMENT DATES OCCURRING DURING QUARTERLY TESTING PERIODS]

											
	Consolidated EBITDA

 
	 	Quarter Ended

 	 	Quarter Ended

 	 	Quarter Ended

 	 	Quarter Ended

 	 	Four Quarters Ended

 
	 Consolidated Net Income
	 	 	 	 	 	 	 	 	 	 
	 + Consolidated Interest Charges
	 	 	 	 	 	 	 	 	 	 
	 + income taxes
	 	 	 	 	 	 	 	 	 	 
	 + depreciation expense
	 	 	 	 	 	 	 	 	 	 
	 + amortization expense
	 	 	 	 	 	 	 	 	 	 
	 + non-recurring non-cash expenses
	 	 	 	 	 	 	 	 	 	 
	 + add-backs
	 	 	 	 	 	 	 	 	 	 
	 - income tax credits
	 	 	 	 	 	 	 	 	 	 
	 - non-cash income
	 	 	 	 	 	 	 	 	 	 
	 - gains (+ losses) from dispositions of capital assets
	 	 	 	 	 	 	 	 	 	 
	 - extraordinary gains (+ losses) net of related tax effects
	 	 	 	 	 	 	 	 	 	 
	 = Consolidated EBITDA
	 	 	 	 	 	 	 	 	 	 
	
  Minimum Consolidated EBITDA required under Section 7.11(c) (see Annex to Schedule for
determination of Minimum Consolidated EBITDA):
	 	 

 ANNEX TO

SCHEDULES 2-A, 2-B AND 2-C
  to Compliance Certificate

($ in 000's) 

 Minimum Consolidated EBITDA  

						
	 Minimum Consolidated EBITDA required under Section 7.11(c):
	 	 	 	 
	 Twelve Calendar Months Ending:
	 	 	 	 
	 	 April 30, 2008
	 	$	27.00	 
	 	 May 31, 2008
	 	$	20.50	 
	 	 June 30, 2008
	 	$	21.50	 
	 	 July 31, 2008
	 	$	22.50	 
	 	 August 31, 2008
	 	$	23.00	 
	 	 September 30, 2008
	 	$	26.00	 
	 	 October 31, 2008
	 	$	26.00	 
	 	 November 30, 2008
	 	$	26.50	 
	 	 December 31, 2008
	 	$	16.75	 
	 	 January 31, 2009
	 	$	17.50	 
	 	 February 28, 2009
	 	$	18.00	 
	 	 March 31, 2009
	 	$	18.50	 
	 	 April 30, 2009
	 	$	19.25	 
	 	 May 31, 2009
	 	$	21.25	 
	 	 June 30, 2009
	 	$	22.00	 
	 Four Fiscal Quarters Ending:
	 	 	 	 
	 	 September 30, 2009
	 	$	23.00	 
	 	 December 31, 2009
	 	$	24.00	 
	 	 March 31, 2010
	 	$	24.50	 
	 	 June 30, 2010 and each period of four fiscal quarters ending thereafter
	 	$	25.50	 

 EXHIBIT E  

 FORM OF MONTHLY COMPLIANCE CERTIFICATE  

Calendar
month ending:                        ,        

	To:
	Bank
of America, N.A., as Administrative Agent 

Ladies
and Gentlemen: 

        Reference
is made to that certain Second Lien Credit Agreement, dated as of August 8, 2007 (as amended, restated, extended, supplemented or otherwise modified in writing from time
to time, the "Agreement"), among Prospect Medical Holdings, Inc., a Delaware corporation
("Holdings"), Prospect Medical Group, Inc., a California professional corporation (collectively with Holdings, the
"Borrowers"), the Lenders from time to time party thereto, and Bank of America, N.A., as Administrative Agent.
Capitalized terms used herein and not defined herein shall have the meanings assigned thereto in the Agreement. 

        1.     This
Monthly Compliance Certificate is delivered in accordance with Section 6.02(c) of the Agreement. 

        2.     Attached
hereto as Schedule 1 is information required in connection with  Section 6.02(c) of the Credit Agreement for the calendar month set forth above,
and all such information is true and accurate on and as of the
date of this Certificate. 

        IN WITNESS WHEREOF, the undersigned has executed this Certificate as
of                             ,        . 

					
	 
	 	 
	 	 

	    
	 	 	 	 
	
	 	PROSPECT MEDICAL HOLDINGS, INC.
	    
	 	 	 	 
	
	 	By:	 	 

	
	 	Name:	 	  

	
	 	Title:	 	  

For
the Month ended                                    ("Statement Date") 

 
 

  SCHEDULE 1
  to the Monthly Compliance Certificate    
    

							
	I.	 	Consolidated Membership.	 	 	 	 
	A. 	 	Consolidated Membership for month ending on the Statement Date	 	 	 	 
	B. 	 	Consolidated Membership for the month ending on the immediately prior Statement Date	 	 	 	 
	C. 	 	Percentage change of consolidated Membership [(Line I.A - Line I.B) ÷ Line I.B] × 100	 	 	 	%
	II.	 	Senior Members versus Commercial Members.	 	 	 	 
	A. 	 	The number of senior members for month ending on the Statement Date	 	 	 	 
	B. 	 	The number of senior members for month ending on the immediately prior Statement Date	 	 	 	 
	C. 	 	Percentage change of senior members [(Line II.A - Line II.B) ÷ Line II.B] × 100	 	 	 	%
	D. 	 	The number of commercial members for month ending on the Statement Date	 	 	 	 
	E. 	 	The number of commercial members for month ending on the immediately prior Statement Date	 	 	 	 
	F. 	 	Percentage change of commercial members [(Line II.D - Line II.E) ÷ Line II.E] × 100	 	 	 	%
	III.    Summary of material variances noted within the comparison (i.e., a summary of any terminations of existing contracts in connection with the Membership during the period covered by such
certificate and its effect on Membership):	 

QuickLinks

Exhibit 10.9

SCHEDULE 1 to the Monthly Compliance CertificateQuickLinks
 -- Click here to rapidly navigate through this document
 

 
 

  Exhibit 10.10    
    

 
    SEVERANCE AND RELEASE AGREEMENT    
    

        This Severance and Release Agreement ("Agreement") is made and entered into by and between Prospect Medical Holdings, Inc., on
behalf of itself and its subsidiaries, parents, affiliates, successors and assigns, and all of their agents, officers and directors, employees and former employees, and other representatives
(collectively "Prospect"), on the one hand, and Michael Terner ("Terner"), an individual, on the other hand (Prospect and Terner are collectively, the "Parties"). 

        WHEREAS,
Terner is employed by Prospect as its Executive Vice President; 

        WHEREAS,
Terner also serves as a director for Prospect subsidiaries, including Prospect Medical Systems, Inc., Sierra Medical Management, Inc., Prospect Hospital Advisory
Services, Inc., and Pinnacle Health Resources; 

        WHEREAS,
Prospect and Terner mutually agree that Terner's employment with Prospect shall end on the terms and conditions described herein; 

        NOW,
THEREFORE, in consideration of the covenants herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by the Parties,
intending to be legally bound hereby, the Parties agree as follows: 

        1.     Employment Separation Date.    Terner acknowledges that his last day of employment with Prospect is
June 4, 2008 ("Employment Separation Date"). Terner also acknowledges that he will perform no further duties, functions, services, or work for Prospect or its subsidiaries, as an employee,
director or in any other capacity, subsequent to the Employment Separation Date. On the Employment Separation Date, Prospect will issue to Terner his final paycheck, representing all wages,
compensation, accrued and unused vacation to which he is entitled. Terner acknowledges and agrees that except for the amounts due to him in his final paycheck, he has received all monies, bonuses,
compensation, remuneration he earned or was due through the Employment Separation Date. 

        2.     Consideration.    In consideration for the promises made herein, including, but not limited to, Terner's
agreement to the release of all claims in the release, paragraph 5 of this Agreement, Prospect agrees to provide Terner with the following, upon satisfaction of the terms identified herein.
Prospect shall pay Terner three (3) months of his regular base salary, a total of Forty Five Thousand Dollars ($45,000). Terner further agrees that this payment will be subject to income tax
and other legally required withholding, and will be reported by Prospect as income to Terner on an IRS Form W-2. Following the execution of this Agreement, Prospect will pay Terner
Fifteen Thousand Dollars ($15,000) on July 7, August 7, and September 5, 2008, unless Terner chooses to revoke the Agreement during the revocation period described in
paragraph 7. 

        3.     Payment of Moneys Owed.    Terner acknowledges that Prospect has paid all moneys owed to him as a result of his
employment with Prospect, including but not limited to his salary and all accrued paid time off pay through his Employment Separation Date. 

        4.     Non-Admission of Liability.    While this Agreement resolves all issues between Prospect and Terner,
as well as any future effects of any acts or omissions, it does not constitute an admission by Prospect of any violation of any federal, state or local law, ordinance or regulation or of any violation
of Prospect's policies or procedures or of any liability or wrongdoing whatsoever. Neither this Agreement nor anything in this Agreement shall be construed to be or shall be admissible in any
proceeding as evidence of liability or wrongdoing by Prospect. 

        5.     General Release.    In consideration of the covenants undertaken herein by Prospect, and except for those
obligations created by or arising out of this Agreement, Terner, on his own behalf and on behalf of his descendants, dependents, heirs, executors, administrators, assigns and successors, does 

1

 

hereby
covenant not to sue and acknowledges complete satisfaction of and hereby releases, absolves and discharges Prospect and its owners, heirs, successors and assigns, parents, subsidiaries,
divisions and Affiliates, past, present and future, and including without limitation their trustees, directors, officers, shareholders, members, managers, employees, attorneys, insurers, lenders,
brokers, consultants and any other agents, past, present and future, and each of them (hereinafter collectively referred to as "Releasees"), with respect to and from any and all claims, demands,
liens, agreements, contracts, covenants, actions, suits, causes of action, wages, obligations, debts, expenses, attorneys' fees, damages, judgments, orders and liabilities of whatever kind or nature
in law, equity or otherwise, whether now known or unknown, suspected or unsuspected, and whether or not concealed or hidden, which Terner now owns or holds or has at any time heretofore owned or held
as against said Releasees, or any of them, including specifically but not exclusively and without limiting the generality of the foregoing, any and all claims, demands, agreements, obligations and
causes of action, known or unknown, suspected or unsuspected by Terner: (1) arising out of or in any way connected with Terner's Employment; or (2) arising out of or in any way connected
with any transactions, occurrences, acts or omissions set forth, or facts alleged, in any and all charges, complaints, claims or pleadings filed by Terner against any Releasee prior to the date hereof
with any city, county, state or federal agency, commission, office or tribunal whatsoever; or (3) arising out of or in any way connected with any transactions, occurrences, acts or omissions
occurring prior to the date hereof, including specifically without limiting the generality of the foregoing any claim under Title VII of the Civil Rights Act of 1964, as amended, the Equal Pay Act,
the Employee Retirement Income Act, the Family Medical Leave Act, the Age Discrimination in Employment Act, the Americans with Disabilities Act, the California Fair Employment and Housing Act, the
California Labor Code, the California Family Rights Act, or any claim for severance pay, bonus, sick leave, holiday pay, vacation pay, paid time off, life insurance, health and medical insurance or
any other fringe benefit, workers' compensation or disability, or any claim based on an express or implied contract, or any claim based on common law, any statute, any constitutional provision or any
administrative regulation. 

        6.     Waiver.    It is a further condition of the consideration hereof and is the intention of Terner in executing
this Agreement that the same shall bar each and every claim, demand and cause of action hereinabove specified and, in furtherance of this intention, Terner hereby expressly waives any and all rights
or benefits conferred by the provisions of Section 1542 of the California Civil Code and expressly consents that this Agreement shall be given full force and effect according to each and all of
its express terms and conditions, including those relating to unknown and unsuspected claims, demands and causes of actions, if any, as well as those relating to any other claims, demands and causes
of actions hereinabove specified. Section 1542 provides: 

"A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE
MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR." 

Terner
acknowledges that he may hereafter discover claims or facts in addition to or different from those which Terner now knows or believes to exist with respect to the subject matter of this
Agreement and which, if known or suspected at the time of executing this Agreement, may have materially affected this settlement. Nevertheless, Terner hereby waives any right, claim or cause of action
that might arise as a result of such different or additional claims or facts. 

        7.     Review and Revocation of Rights.    Terner expressly acknowledges and agrees that, by entering into this
Agreement, he is waiving any and all rights or claims that he may have arising under the Age Discrimination in Employment Act of 1967 ("ADEA"), as amended by the Older Workers' Benefit 

2

 

Protection
Act of 1990 ("OWBPA"), which have arisen on or before the date of execution of this Agreement. Terner further expressly acknowledges and agrees that: 

	a.
	Terner
is knowingly and voluntarily waiving any and all rights and claims he may have under the ADEA and OWBPA;

	b.
	In
return for this Agreement, he will receive compensation beyond that which he was already entitled to receive before entering into this Agreement;

	c.
	He
was advised by Prospect to consult with an attorney before signing this Agreement;

	d.
	He
was given a copy of this Agreement on June 2, 2008, and informed that he had 21 days within which to consider this Agreement; and

	e.
	He
was informed that he has seven days following the date of execution of this Agreement in which to revoke this Agreement. 

        Terner
may revoke this Agreement in its entirety during the seven days following Terner's execution of this Agreement. Any revocation of the Agreement must be in writing and hand
delivered during the revocation period to Prospect, c/o General Counsel, 11500 W. Olympic Blvd, Suite 502, Los Angeles, CA 90064; Facsimile (310) 943-4504. This Agreement
will become effective and enforceable seven days following execution by Terner, unless it is revoked during the seven-day period. 

        8.     Confidentiality of Agreement.    Terner agrees that the terms and conditions of this Agreement shall remain
confidential as between the parties and he shall not disclose them to any other person, other than Terner's legal and financial advisors who shall also be advised of its confidentiality and who shall
agree to be bound by this confidentiality agreement. Without limiting the generality of the foregoing, Terner must not respond to or in any way participate in or contribute to any public discussion,
notice or other publicity concerning or in any way relating to the execution or the terms of this Agreement. Without limiting the generality of the foregoing, Terner specifically agrees that he will
not disclose information regarding this Agreement to any current or former employee of Prospect or its Affiliates. 

        9.     Non-disclosure of Confidential Information.    Terner acknowledges that by reason of his position
with Prospect, Terner has been given access to confidential materials or information respecting Prospect's business affairs and other information pertaining to Prospect, the owners of Prospect, or any
other Affiliates of Prospect. Such information shall be broadly construed as any information pertaining to Prospect, the owners of Prospect, or any other Affiliates of Prospect. Terner represents that
he has held all such information confidential and will continue to maintain such confidentiality, and that Terner will not use such information and relationships for any purposes whatsoever without
the prior written consent of Prospect. 

        10.   Non-solicitation.    Terner shall not, either directly or indirectly: (a) call on, solicit,
or take away any customers of Prospect or any of its Affiliates, either for Terner or for any other person or entity; or (b) solicit or take away or attempt to solicit or take away any
employees or contractors of Prospect or any of its Affiliates, either for Terner or for any other person or entity. 

        11.   Non-disparagement.    Terner shall refrain from making any statements or comments of a defamatory
or disparaging nature to any third party regarding Prospect, the owners of Prospect or any of their Affiliates, directors, officers, employees, personnel, policies or services; provided, however, that
it shall not be a violation of this Section for Terner to make truthful statements when required to do so by a court of law, by any governmental agency having supervisory authority over the party, or
by any administrative or legislative body with apparent jurisdiction to order the party to divulge, disclose or make accessible such information. 

3

 

        12.   No Representations.    Terner has not relied upon any advice from Prospect or its attorneys as to the necessity
for withholding or the taxability of such payment, whether pursuant to federal, state or local income tax statutes or otherwise. 

        13.   Entire Agreement.    This Agreement constitutes and contains the entire agreement and final understanding
concerning the subject matters addressed herein between the parties. Notwithstanding the foregoing, the obligations of Terner under any non-compete, non-disclosure,
confidentiality and/or non-solicitation agreements that Terner had entered with Prospect shall continue in accordance with terms and conditions of such agreements. 

        14.   Severability.    If any provision of this Agreement or the application thereof is held invalid, with the
exception of paragraph 5, the invalidity shall not affect other provisions or applications of this Agreement which can be given effect without the invalid provisions or application and to this
end the provisions of this Agreement are declared to be severable. 

        15.   Governing Law.    This Agreement shall be deemed to have been executed and delivered within the State of
California, and the rights and obligations of the parties hereunder shall be construed and enforced in accordance with, and governed by, the laws of the State of California. 

        16.   Counterparts.    This Agreement may be executed in counterparts, and each counterpart, when executed, shall
have the efficacy of a signed original. Photographic copies of such signed counterparts may be used in lieu of the originals for any purpose. 

        17.   No Modification or Waiver.    No modification or waiver of the terms of this Agreement shall be effective
unless it appears in a writing signed by all parties to this Agreement. 

        18.   Successors.    This Agreement shall be binding upon Terner and Prospect, and their respective heirs,
representatives, executors, administrators, successors, and assigns, and shall inure to the benefit of each and all of the Releasees, and to their heirs, representatives, executors, administrators,
successors, and assignees. 

        19.   Execution.    In entering into this Agreement, Terner represents that he has had the opportunity to seek the
advice of his attorney, and that he has completely read the terms of this Agreement and that those terms are fully understood and voluntarily accepted by him. 

PLEASE
READ CAREFULLY. THIS AGREEMENT INCLUDES A RELEASE OF ALL KNOWN AND UNKNOWN CLAIMS. 

        IN
WITNESS WHEREOF, the Parties have executed this Agreement on the dates indicated below. 

					
	MICHAEL TERNER	 	 	 	 
	

 	
 	

 	
 	

 
	Date: June 4, 2008	 	By:	 	/s/ MICHAEL TERNER

Michael Terner
	

 	
 	

 	
 	

 
	PROSPECT MEDICAL HOLDINGS, INC.	 	 	 	 
	

 	
 	

 	
 	

 
	Date: June 4, 2008	 	By:	 	/s/ SAMUEL S. LEE

Samuel S. Lee

Chief Executive Officer

4

QuickLinks

Exhibit 10.10

SEVERANCE AND RELEASE AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00146-of-00352.parquet"}]]